GLA
NBIX icon

Great Lakes Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Great Lakes Advisors’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$840K Buy
4,983
+1,290
+35% +$191K 0.01% 549
2026
Q1 		$487K Sell
3,693
-59
-2% -$7.83K ﹤0.01% 601
2025
Q4 		$532K Buy
3,752
+147
+4% +$21.3K ﹤0.01% 599
2025
Q3 		$506K Buy
3,605
+84
+2% +$11.4K ﹤0.01% 617
2025
Q2 		$443K Sell
3,521
-28,485
-89% -$3.27M ﹤0.01% 634
2025
Q1 		$3.54M Buy
32,006
+27,431
+600% +$3.47M 0.03% 341
2024
Q4 		$624K Sell
4,575
-5,832
-56% -$721K 0.01% 630
2024
Q3 		$1.2M Sell
10,407
-100,871
-91% -$13.8M 0.01% 561
2024
Q2 		$15.3M Sell
111,278
-4,339
-4% -$595K 0.14% 149
2024
Q1 		$15.9M Sell
115,617
-47,868
-29% -$6.54M 0.14% 154
2023
Q4 		$21.5M Buy
163,485
+1,528
+0.9% +$176K 0.21% 122
2023
Q3 		$18.2M Buy
161,957
+121,592
+301% +$12.8M 0.17% 129
2023
Q2 		$3.81M Sell
40,365
-43,349
-52% -$4.24M 0.04% 380
2023
Q1 		$8.47M Buy
83,714
+41,488
+98% +$4.32M 0.08% 248
2022
Q4 		$5.04M Sell
42,226
-878
-2% -$103K 0.29% 124
2022
Q3 		$4.58M Buy
+43,104
New +$4.37M 0.1% 225
2018
Q4 		– Sell
-75,389
Closed -$9.27M – 606
2018
Q3 		$9.27M Buy
+75,389
New +$8.55M 0.2% 113

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Great Lakes Advisors's NBIX Position: Q2 2026 in Review

Great Lakes Advisors increased its Neurocrine Biosciences (NBIX) stake by 35% in Q2 2026, buying an estimated $191K and bringing the position to 4,983 shares worth $840K. The position accounts for 0.01% of the portfolio, ranked #549.

Great Lakes Advisors first reported a position in NBIX in Q3 2018 and has held it in 17 quarters since. The position peaked at $21.5M in Q4 2023. 781 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Great Lakes Advisors held 4,983 shares of Neurocrine Biosciences worth $840K as of Q2 2026.
  • Great Lakes Advisors bought 1,290 Neurocrine Biosciences shares in Q2 2026, an estimated $191K.
  • Neurocrine Biosciences made up 0.01% of Great Lakes Advisors's portfolio in Q2 2026, its #549 holding.
  • Great Lakes Advisors first reported a position in Neurocrine Biosciences in Q3 2018 and has held it in 17 quarters since.
  • Great Lakes Advisors's Neurocrine Biosciences position peaked at $21.5M in Q4 2023.
  • 781 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Great Lakes Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.